Biotech China 2014
Toronto Heart Summit
Four Seasons Hotel (Regency Ballroom)
21 Avenue Road Toronto, Ontario, M5R2G1 Tel: (416) 964-0411.
Toronto, Ontario
http://www.torontohfsummit.com/faculty.html
Cardiovascular disease is a global health problem with no geographic, gender, or socio-economic boundaries. Despite the tremendous advances recently made in cardiac care, including drugs, devices, and diagnostic innovation, many patients continue to die from heart disease or live with significant morbidity. Challenges for the next decade include health promotion and disease prevention, obesity and diabetes, and acute heart failure and cardiorenal disease. We must broaden our scope of intervention to emphasize and extend preventive strategies, and translate our innovations into actions through carefully designed health policy strategies. Genomic and proteomic biomarkers promise to improve early detection and risk stratification, leading to a more personalized approach to cardiovascular medicine.

This conference brings together the most exciting advances in cardiovascular disease and related cardiometabolic and cardiorenal medicine, from treatment to prevention, and innovation to application. The program is unique because of its translational theme. The global faculty and participating audience present the faces of cardiovascular medicine with a truly international perspective.

To enhance the learning experience, the meeting features lectures, panel discussion, problem-solving sessions and case presentations to foster interaction between the faculty and the participants. The workshops will be particularly valuable in translating theoretical concepts and guidelines to individual cases in practice. This year our participants will have the opportunity to present their research work in our poster sessions.

Upon completion of this program participants should be able to:

    *
      Choose effective imaging strategies for the assessment of ischemic disease and heart failure
    *
      Recognize moving targets in risk factor management and implement preventative cardiology recommendations and advocate health promotion
    *
      Review the latest guidelines and surrogate marker targets for diabetic heart disease
    *
      Better understand the pathophysiology and management of cardiorenal disease
    *
      Implement the latest rhythm and device strategies
    *
      Review the etiology and prevalence of cardiomyopathies and infectious heart disease and how to approach diagnostic and therapeutic challenges
    *
      Discuss new treatment therapies and recent scientific advancements in acute coronary syndrome and heart failure management
    *
      Discuss clinical practice guidelines, late breaking trials results and the impact on cardiovascular care

http://www.torontohfsummit.com/faculty.html

Schedule of Presentations:

Thursday, June 9, 2011
07:00:00 Registration and Breakfast
07:50:00 Official Welcome and Introduction
07:55:00 FUTURE OF CARDIOVASCULAR MEDICINE
08:00:00 Guidelines and Scientific Evidence | Opportunities to Improve Cardiovascular care
08:25:00 Global Cardiovascular Health is a Developmental Challenge
08:50:00 Novel Pathways Regulating Ischemic Injury | Are We Ready for Clinical Trials? Thomas Force
09:15:00 Clinical Trials Update - Cardiovascular Management in 2011 Michael Farkouh
09:40:00 Active Learning Q & A with Panel
10:00:00 Health Break
10:25:00 PREVENTING CARDIOVASCULAR DISEASE IN 2011
10:30:00 Moving Targets in Risk Factor Management Robert A. Hegele
10:50:00 Global Efforts to Reduce Dietary Salt Norman R.C. Campbell
11:10:00 Early Determinants of Risk of Childhood Obesity and Type 2 Diabetes Stephanie A. Atkinson
11:30:00 Is Bariatric Surgery the Cure for Diabetes? Peter F. Crookes
11:50:00 Active Learning Q & A with Panel
12:10:00 Simultaneous Session II | Update of Tx on Inflammatory Cardiomyopathies Heinz-Peter Schultheiss
12:10:00 Innovative Information Technology to Help You Manage Your Patient Chi-Ming Chow
12:30:00 LUNCH
13:25:00 Simultaneous Session I | IMAGING TO DIRECT THERAPIES IN HEART FAILURE Robert S. B. Beanlands
13:25:00 Simultaneous Session II | CARDIAC FIBROSIS IN CARDIOMYOPATHIES Mansoor Husain
13:30:00 Myocardial Viability and the Decision for Revascularization
13:30:00 Simultaneous Session II | New Insights into Molecular Mechanisms of Cardiac Hypertrophy and Failure Issei Komuro
13:50:00 Simultaneous Session II | Inflammatory Cardiomyopathies
13:50:00 Neurohormonal Imaging and Implantable Cardioverter-Defibrillator Therapy
14:10:00 Defining Scar to Direct Cardiac Resynchronization Therapy James White
14:30:00 Simultaneous Session II | Hypertrophic Cardiomyopathy Masakazu Yamagishi
14:30:00 A Heart Failure MD’s Perspective - Translating the Evidence into Practice
14:50:00 Simultaneous Session II | Active Learning Q & A with Panel
14:50:00 Active Learning Q & A with Panel
15:10:00 Health Break
15:10:00 Simultaneous Session II | Health Break
15:35:00 ARRHYTHMIAS AND DEVICES Paul Dorian
15:40:00 Results of the RAFT Study
16:00:00 Effects of Bi-Ventricular Pacing on Arrhythmias Paul Dorian
16:20:00 New Canadian Cardiovascular Society Guidelines for Atrial Fibrillation: What’s New? Allan C. Skanes
16:40:00 Risk of Stroke Related to Atrial Fibrillation
17:00:00 Active Learning Q & A with Panel
17:20:00 POSTER SESSION I (Moderated)
19:00:00 Adjournment
Friday, June 10, 2011
07:00:00 Registration and Breakfast
07:55:00 CHALLENGES OF HEART- KIDNEY INTERACTIONS James W. Scholey
08:00:00 Chronic Kidney Disease and Cardiovascular Risk: Where Are We Now and Where Do We Go From here?
08:20:00 Sudden Death and Chronic Kidney Disease Paul Dorian
08:40:00 Arterial Stiffness and Chronic Kidney Disease
09:00:00 Atherosclerotic Renal Disease in the United States Robert N. Foley
09:20:00 Active Learning Q & A with Panel
09:40:00 Health Break
09:55:00 UPDATE ON CLINICAL TRIALS Michael Farkouh
10:00:00 AVERROES Stuart J. Connolly
10:20:00 VAD Clinical Trials Update Heather Ross
10:40:00 STICH Update Vivek Rao
11:00:00 TAVI and Implications of the PARTNER Trial Eric Horlick
11:20:00 Active Learning Q & A with Panel
11:40:00 Simultaneous Session III | CANADIAN CARDIOVASCULAR HARMONIZED GUIDELINES ENDEAVOUR (C_CHANGE)
11:40:00 Simultaneous Session IV | INFECTIOUS AND INFLAMMATORY HEART DISEASE
11:45:00 Simultaneous Session IV | Long Term Outcome of Revascularization for Pediatric Kawasaki Disease Soichiro Kitamura
11:45:00 Simultaneous Session III | Time to C-Change in Cardiovascular Disease Clinical Practice Guidelines James C Stone
12:05:00 Simultaneous Session III | Methodology of Harmonized Guidelines Sheldon W. Tobe
12:05:00 Simultaneous Session IV | Role of Viral Infection in Atherosclerosis Nobukazu Ishizaka
12:25:00 Simultaneous Session III | Implementation of Guidelines Onil K. Bhattacharyya
12:25:00 Simultaneous Session IV | Chagas Disease
12:45:00 Simultaneous Session IV | Cardiovascular Effects of HCV Infection
12:45:00 Simultaneous Session III | Outcomes Assessments to Examine the Impact of Recommendations Programs. The Canadian Hypertension Experience Norman R.C. Campbell
13:05:00 Simultaneous Session III | Active Learning Q & A with Panel
13:05:00 Simultaneous Session IV | Active Learning Q & A with Panel
13:25:00 POSTER SESSION II (Moderated) | LUNCH
14:55:00 WORKSHOPS AND CASE DISCUSSIONS | Interactive; Participants are encouraged to bring own cases for discussion
15:00:00 Management of Cardiorenal patients Christopher Chang
15:20:00 How to Improve HF Management using Device Diagnostics? J. Malcolm O. Arnold
15:35:00 Challenges of Atrial Fibrillation | Case Presentations Allan C. Skanes
16:00:00 CCS 2011 NATIONAL WORKSHOP INITIATIVE Robert McKelvie
18:00:00 Adjournment
18:30:00 SOCIAL EVENT
Saturday, June 11, 2011
07:30:00 Registration and Breakfast
08:15:00 ACUTE MI/INTERVENTION
08:20:00 Overview of Current STEMI Trials 2011
08:40:00 Novel Pharmacotherapies for ST Elevation MI: What’s Showing Promise?
09:00:00 Use of Adjunct Thrombectomy Catheter for STEMI Eric Cohen
09:20:00 Active Learning Q & A with Panel
09:35:00 HEART FAILURE J. Malcolm O. Arnold
09:40:00 Acute Heart Failure Syndromes: An Update 2011 Mihai Gheorghiade
10:00:00 Biomarkers and HF Management
10:20:00 Health Break
10:45:00 SHIFT Update
11:05:00 EMPHASIS HF Faiez Zannad
11:25:00 Active Learning Q & A with Panel
11:40:00 DIABETES AND CARDIOVASCULAR DISEASE Michael Farkouh
11:45:00 Relationship of Albuminuria In Cardiovascular Risk Matthew R Weir
12:05:00 Cardio-Metabolic Recommendations David Fitchett
12:25:00 New Target for Diabetes Therapy
12:45:00 Incretin from Bench to Bedside Mansoor Husain
13:05:00 Active Learning Q & A with Panel
13:25:00 Summary and Concluding Remarks
13:35:00 Adjournment
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.